Re: RVX-297 -- Twice as selective for BD2 as is apabetalone

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

golfyeti

Rank: Vice President [?]

Points: 24483 [?]

Votes: 217 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: RVX-297 -- Twice as selective for BD2 as is apabetalone

in response to

RVX-297 -- Twice as selective for BD2 as is apabetalone

golfyeti

posted on May 30, 2022 02:45PM

BTW, the approved MS drug fingolimod, known as Gilenya brings in for Novartis $2.8 Billion USD per year.

To think that we may have a greatly superior drug for MS and the world will never benefit from it in our lifetimes.

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply